Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now.
BSE: 0 | NSE: CLSL | Pesticides & Agrochemicals | Small Cap
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Crop Life Science Ltd is a below average quality company.
The key valuation ratios of Crop Life Science Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Crop Life Science Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|
| ROCE % ⓘ | 10.2% | 10.3% | 7.8% | 10.3% | - |
| Value Creation Index ⓘ | -0.3 | -0.3 | -0.4 | -0.3 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||
| Sales ⓘ | 135 | 119 | 102 | 131 | 131 |
| Sales YoY Gr. | - | -12% | -14.2% | 28.6% | - |
| Adj EPS ⓘ | 2.7 | 3.1 | 2.3 | 3.4 | 2.4 |
| YoY Gr. | - | 15.1% | -24.9% | 48.9% | - |
| BVPS (₹) ⓘ | 24.8 | 27.6 | 30 | 33.8 | 39.3 |
| Adj Net Profit ⓘ | 3.2 | 3.7 | 2.8 | 4.1 | 4 |
| Cash Flow from Ops. ⓘ | 2.5 | 3.5 | -0.2 | 2.3 | - |
| Debt/CF from Ops. ⓘ | 6.3 | 5 | -144 | 11.4 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | -1% | 28.6% | ||||
| Adj EPS ⓘ | NA | NA | 8.8% | 48.9% | ||||
| BVPSⓘ | NA | NA | 11% | 12.6% | ||||
| Share Price | - | - | - | - | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|
| Return on Equity % ⓘ | 10.7 | 11.6 | 8 | 10.7 | 6.5 |
| Op. Profit Mgn % ⓘ | 6.1 | 7.4 | 7.6 | 9 | NAN |
| Net Profit Mgn % ⓘ | 2.4 | 3.1 | 2.7 | 3.1 | 3.1 |
| Debt to Equity ⓘ | 0.5 | 0.5 | 0.6 | 0.6 | - |
| Working Cap Days ⓘ | 0 | 207 | 274 | 234 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 98 | 122 | 97 | 0 |
Debt to equity has declined versus last 3 years average to 0.64
Return on Equity has declined versus last 3 years average to 6.50%
Sales growth has been subdued in last 3 years -0.97%
Net Profit has been subdued in last 3 years 8.77%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 2.4 | - |
| TTM Sales (₹ Cr.) | 131 | - |
| BVPS (₹.) ⓘ | 39.3 | - |
| Reserves (₹ Cr.) ⓘ | 50 | - |
| P/BV ⓘ | 1.08 | - |
| PE ⓘ | 17.89 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 0.00 / 0.00 |
| All Time Low / High (₹) | - / - |
| Market Cap (₹ Cr.) | 72.8 |
| Equity (₹ Cr.) | 17.1 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 35.9 |
| Pledged * | 0.00 | 0.00 |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|
| Sales | 135.13 | 118.93 | 102.01 | 131.23 |
| Operating Expenses ⓘ | 126.86 | 110.19 | 94.30 | 119.45 |
| Manufacturing Costs | 7.38 | 8.83 | 6.61 | 7.99 |
| Material Costs | 90.67 | 67.56 | 59.43 | 92.20 |
| Employee Cost | 9.84 | 11.06 | 10.88 | 11.29 |
| Other Costs ⓘ | 18.96 | 22.74 | 17.38 | 7.97 |
| Operating Profit ⓘ | 8.27 | 8.74 | 7.71 | 11.77 |
| Operating Profit Margin (%) | 6.1% | 7.3% | 7.6% | 9.0% |
| Other Income ⓘ | 0.18 | 0.57 | 0.38 | 0.80 |
| Interest ⓘ | 2.11 | 1.87 | 2.07 | 3.27 |
| Depreciation ⓘ | 1.75 | 2.52 | 2.25 | 3.71 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 4.59 | 4.93 | 3.77 | 5.60 |
| Tax ⓘ | 1.36 | 1.22 | 0.95 | 1.53 |
| Profit After Tax | 3.23 | 3.70 | 2.81 | 4.07 |
| PAT Margin (%) | 2.4% | 3.1% | 2.8% | 3.1% |
| Adjusted EPS (₹) | 2.7 | 3.1 | 2.4 | 3.4 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 29.70 | 33.15 | 36.02 | 40.55 | ||||||
| Share Capital ⓘ | 12 | 12 | 12 | 12 | ||||||
| Reserves ⓘ | 17.70 | 21.15 | 24.02 | 28.55 | ||||||
| Minority Interest | 0 | 0 | 0 | 0 | ||||||
| Debt | 13.44 | 16.16 | 19.16 | 22.24 | ||||||
| Long Term Debt | 1.26 | 3.09 | 1.68 | 5.53 | ||||||
| Short Term Debt | 12.18 | 13.06 | 17.48 | 16.72 | ||||||
| Trade Payables | 18 | 19.93 | 22.23 | 19.99 | ||||||
| Others Liabilities ⓘ | 16.47 | 18.61 | 18.32 | 20.32 | ||||||
| Total Liabilities ⓘ | 77.61 | 87.85 | 95.73 | 103.10 | ||||||
Fixed Assets | ||||||||||
| Gross Block | 13.77 | 16.91 | 15.15 | 23.21 | ||||||
| Accumulated Depreciation | 1.75 | 4.05 | 3.92 | 7.63 | ||||||
| Net Fixed Assetsⓘ | 12.01 | 12.87 | 11.23 | 15.58 | ||||||
| CWIP ⓘ | 0 | 0 | 1.45 | 0 | ||||||
| Investmentsⓘ | 0 | 0 | 0 | 0 | ||||||
| Inventories | 23 | 29.37 | 22.26 | 26.19 | ||||||
| Trade Receivables | 27.43 | 26.09 | 36.86 | 32.56 | ||||||
| Cash Equivalents | 2.31 | 3.09 | 2.07 | 0.38 | ||||||
| Others Assetsⓘ | 12.86 | 16.44 | 21.86 | 28.40 | ||||||
| Total Assets ⓘ | 77.61 | 87.85 | 95.73 | 103.10 | ||||||
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 2.51 | 3.50 | -0.15 | 2.27 |
| PBT ⓘ | 4.59 | 4.93 | 3.77 | 5.60 |
| Adjustment ⓘ | 4.10 | 4.17 | 4.51 | 6.20 |
| Changes in Working Capital ⓘ | -4.86 | -4.06 | -7.41 | -7.77 |
| Tax Paid ⓘ | -1.31 | -1.53 | -1.02 | -1.75 |
| Cash Flow From Investing Activity ⓘ | -0.74 | -2.15 | -1.99 | -4.48 |
| Capex | -0.75 | -2.15 | -2 | -5.02 |
| Net Investments | 0 | 0 | 0 | 0 |
| Others ⓘ | 0.01 | 0.01 | 0.01 | 0.53 |
| Cash Flow From Financing Activityⓘ | -2.52 | -0.57 | 1.11 | 0.52 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | -1.34 | 0.64 | -0.96 | 5.85 |
| Interest Paid ⓘ | -2.11 | -1.87 | -2.07 | -3.27 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 |
| Others ⓘ | 0.94 | 0.65 | 4.14 | -2.06 |
| Net Cash Flow ⓘ | -0.75 | 0.78 | -1.02 | -1.69 |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 10.88 | 11.79 | 8.14 | 10.63 | ||||||
| ROCE (%) | 14.67 | 14.11 | 10.86 | 14.37 | ||||||
| Asset Turnover Ratio | 1.74 | 1.44 | 1.11 | 1.32 | ||||||
| PAT to CFO Conversion(x) | 0.78 | 0.95 | -0.05 | 0.56 | Working Capital Days | |||||
| Receivable Days | 74 | 82 | 113 | 97 | ||||||
| Inventory Days | 62 | 80 | 92 | 67 | ||||||
| Payable Days | 72 | 102 | 129 | 84 | ||||||
The company was incorporated as Crop Life Science Limited under the provision of the Companies Act, 1956 vide certificate of incorporation dated May 24, 2006 issued by the Asstt. Registrar of Companies, Ahmedabad and Certificate of Commencement of Business dated July 6, 2006 issued by Registrar of Companies, Ahmedabad.
Since commencement of business of the company, it is an agrochemical company engaged in the business of manufacturing, distributing and marketing of a wide range of agro chemical formulations. Agriculture chemicals consists of Pesticides and Micro Fertilizer, moreover, the pesticides including Insecticides, Fungicides, Herbicides and Weedicides. In the year 2006, it has taken the land from Gujarat Industrial Development Corporation (GIDC) for its manufacturing unit at GIDC Ankleshwar (Gujarat). It had commenced the manufacturing activities of Pesticides and Micro fertilizer in the year 2006-07. In the year 2012, the company started exporting pesticides to Indonesia. Over a period of time, it has started exporting to Bangladesh, Egypt, Myanmar, Vietnam, Sudan and other countries.
The company is required to obtain various licenses and permission from the government and semi government authorities before commencement of manufacturing of pesticides and fertilizer. The licenses and permission such as registration of its products with Central Insecticides Board (CIB), approval from the Directorate of Agriculture, Government of Gujarat and approval from the Gujarat Pollution Control Board (GPCB). With an aim to offer a wide product portfolio across the agri-value chain, it continues to expand its product portfolio by introducing new products. In the year 2007, the company had started production of different range of agro chemical products. Subsequently it keeps on adding agro chemical products year to year in its product portfolio.
With an objective to provide high quality of formulations of agrochemicals to its domestic as well as overseas customers, it has set up state of art manufacturing/formulation units at Ankleshwar, Gujarat. It has a team of qualified technical people for production and quality control. Right from raw material to finished products it keeps stringent quality control check to supply best quality of its products. In addition to marketing of its branded products in India, it is also supplying agrochemical formulations in bulk to reputed companies in India as well as to overseas customers.
Business area of the company
The company is an agrochemical company engaged in the business of manufacturing, distributing and marketing of a wide range of agro chemical formulations.
Products of the company
History and milestone
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
